Market News & Trends
Harlan Contract Research Services & Bertin Pharma Sign Strategic Collaboration
Harlan Contract Research Services and Bertin Pharma recently announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the…
Cobra Biologics & BioCancell Announce Agreement for Promising Cancer Therapy
Cobra Biologics and BioCancell recently announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials. BioCancell’s Phase I clinical trial for BC-821, scheduled…
Croda Celebrates EXCiPACT Double
Croda recently announced it is celebrating two achievements in relation to EXCiPACT, the voluntary scheme that reduces the audit burden in the pharmaceutical industry by…
West Receives CE Mark for Intradermal Adapter for Disposable Syringes
West Pharmaceutical Services, Inc, a leading global developer and manufacturer of components and systems for injectable drug delivery, received CE approval of its Intradermal (ID)…
Thesan Pharmaceuticals Announces $49-Million Financing
Thesan Pharmaceuticals recently announced the closing of a $49-million Series B financing, led by Novo Ventures, with SV Life Sciences and Lundbeckfond Ventures joining Novartis…
Abingworth Raises $375 Million for Life Sciences Fund
Abingworth, the international investment group dedicated to life sciences and healthcare, recently announced the final closing of its $375-million fund, Abingworth Bioventures VI (ABV VI).…
Northwest Biotherapeutics Aims to Dominate Brain Cancer
Ten years ago, cash-strapped biotechnology company Northwest Biotherapeutics Inc. was down to three employees and 1 week from closing its doors when a financial backer…
Tekmira Presents Recent Advances in mRNA Delivery
Tekmira Pharmaceuticals Corporation recently announced that recent advances in the enablement of messenger RNA (mRNA) using Tekmira's lipid nanoparticle (LNP) technology were presented by Tekmira's…
Global Genomics Group & Quintiles to Collaborate
Global Genomics Group (G3) and Quintiles recently announced they will collaborate to investigate novel biomarkers and biological pathways for use in the development of diagnostic…
Metrics, Inc. Expands With Fast-Track Product Development Laboratory
Metrics Inc. is making significant investments in its facilities and equipment for the benefit of contract services clients by opening a new laboratory to better…
Nuvilex Announces $27-Million Funding to Advance Late-Phase Clinical Trials
Nuvilex, Inc. recently announced it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor. Lincoln Park initially…
Nuevolution Announces Exclusive License Agreement
Nuevolution A/S recently announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the…
Roche Signs Licensing Agreement with Sysmex Inostics GmbH
Roche recently announced a licensing agreement with Sysmex Inostics GmbH for its emPCR portfolio of patents. Under the terms of the licensing agreement, Roche grants…
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million…
Actavis to Buy Forest for $25 Billion
Generic drugmaker Actavis Plc said on Tuesday it would buy Forest Laboratories Inc. for about $25 billion in cash and stock, expanding its portfolio of…
Zosano Strikes $115-Million+ Plus Deal
Zosano Pharma, Inc. recently announced it has entered into an agreement with Novo Nordisk to develop a new transdermal presentation of semaglutide, an investigational proprietary…
Sonrgy Secures Exclusive License to Commercialize Drug Delivery Nanotechnology
Sonrgy, Inc. recently announced it has entered into an exclusive license agreement with the University of California for the company’s core technology, an ultrasound-sensitive drug…
West Expands as a Result of Securing Significant Customer Program
Tech Group Europe, a leading medical device manufacturer based in Mulhuddart, Dublin, Ireland, serving the pharmaceutical and medical industries, is expanding its Dublin manufacturing and…
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million…
Mayne Pharma USA Acquires Branded Products
Mayne Pharma USA has begun expanding its North American product portfolio by acquiring well-known branded pharmaceuticals used to treat pain. The company announced it has…